EP0581803A4 - Compositions et procedes de traitement de toute une variete de troubles a l'aide d'etianate et de ses agonistes. - Google Patents

Compositions et procedes de traitement de toute une variete de troubles a l'aide d'etianate et de ses agonistes.

Info

Publication number
EP0581803A4
EP0581803A4 EP19920908745 EP92908745A EP0581803A4 EP 0581803 A4 EP0581803 A4 EP 0581803A4 EP 19920908745 EP19920908745 EP 19920908745 EP 92908745 A EP92908745 A EP 92908745A EP 0581803 A4 EP0581803 A4 EP 0581803A4
Authority
EP
European Patent Office
Prior art keywords
etianate
agonists
compositions
variety
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920908745
Other languages
German (de)
English (en)
Other versions
EP0581803A1 (fr
Inventor
Paolo Alberto Paciucci
James F Holland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of EP0581803A1 publication Critical patent/EP0581803A1/fr
Publication of EP0581803A4 publication Critical patent/EP0581803A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP19920908745 1991-03-21 1992-03-20 Compositions et procedes de traitement de toute une variete de troubles a l'aide d'etianate et de ses agonistes. Withdrawn EP0581803A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67302691A 1991-03-21 1991-03-21
US673026 1991-03-21
US71799591A 1991-06-20 1991-06-20
US717995 1991-06-20

Publications (2)

Publication Number Publication Date
EP0581803A1 EP0581803A1 (fr) 1994-02-09
EP0581803A4 true EP0581803A4 (fr) 1994-03-18

Family

ID=27100871

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920908745 Withdrawn EP0581803A4 (fr) 1991-03-21 1992-03-20 Compositions et procedes de traitement de toute une variete de troubles a l'aide d'etianate et de ses agonistes.

Country Status (4)

Country Link
EP (1) EP0581803A4 (fr)
JP (1) JPH06505491A (fr)
CA (1) CA2105378A1 (fr)
WO (1) WO1992016235A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016196774A1 (fr) * 2015-06-03 2016-12-08 Aelan Cell Technologies, Inc. Procédés et dispositifs pour la production et l'administration de facteurs bénéfiques à partir de cellules souches

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599331A (en) * 1984-12-24 1986-07-08 Syntex (U.S.A.) Inc. Etianic acids as antiangiogenics
US4945089A (en) * 1987-12-29 1990-07-31 Alcon Laboratories, Inc. Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids
US4876250A (en) * 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9216235A1 *

Also Published As

Publication number Publication date
CA2105378A1 (fr) 1992-09-22
WO1992016235A1 (fr) 1992-10-01
JPH06505491A (ja) 1994-06-23
EP0581803A1 (fr) 1994-02-09

Similar Documents

Publication Publication Date Title
GR1002202B (en) Absorbent pads and process thereof.
EP0591303A4 (en) Methods and compositions for treating malaria and other diseases
EP0596962A4 (en) Therapeutic compositions and methods.
HK19496A (en) Use of 1,2,2,3,3-penta-fluoropropane
OA09194A (en) "Insecticidal treatment and compositions therefor".
HUT65702A (en) 1,2-dithiole-3-thione-derivative-based therapeutical compositions
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
GB2269384B (en) Amphoteric surfactants-containing wax compositions, their production and their use
ZA924491B (en) Compositions and use thereof
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
EP0581803A4 (fr) Compositions et procedes de traitement de toute une variete de troubles a l'aide d'etianate et de ses agonistes.
ZA889251B (en) 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro-beta-carbolines
NZ224313A (en) Hetero-ring condensed quinolineamines and pharmaceutical compositions
NZ233400A (en) 1,3-diazine derivatives and pharmaceutical compositions
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
NZ224728A (en) 3-acylaminomethyl-5,6,7,8-tetrahyd-pyridine derivatives and pharmaceutical compositions
JPS6466148A (en) Manufacture of 1,5-diaminoheptanol-6, manufacture and use
EP0548640A3 (en) Process for the preparation of 2,4,5-triamino-6-halopyrimidines and 2-amino-6-halopurines
EP0576914A3 (fr) 14-Désoxy-14-alpha-cardénolied-3-bèta-thiodérivés et compositions pharmaceutiques les contenant pour le traitement des troubles cardiovasculaires.
GB9113011D0 (en) Novel treatment and compositions
GB9113038D0 (en) Novel treatment and compositions
GB9113039D0 (en) Novel treatment and compositions
GB9113042D0 (en) Novel treatment and compositions
IL94658A0 (en) 1,5-diazabicyclodiones and pharmaceutical compositions containing them
ZA909765B (en) Vitamin-mineral treatment methods and compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930917

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

18W Application withdrawn

Withdrawal date: 19940520

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

R18W Application withdrawn (corrected)

Effective date: 19940520